CClinicalTrials.gg
CompletedNCT03689309ObiWEANUpdated Jul 27, 2020

High Flow Oxygen During Spontaneous Breathing Trial in Patients With High Weaning Risk Failure: Impact on the Weaning Course at D7 From the First Spontaneous Breathing Trial.

An interventional study of High Flow Oxygen SBT in Mechanical Ventilation, Mechanical Ventilator Weaning and Endotracheal Extubation, sponsored by Centre Hospitalier Régional d'Orléans. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-27.

Sponsored by Centre Hospitalier Régional d'Orléans · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In intensive care unit (ICU), mechanical ventilation (MV) is part of routine care.

Weaning phase is a daily preoccupation for the caregivers. Prolonged MV can lead to many complications. Failing the weaning phase expose the patient to the need for reintubation, that improves the mortality.

The caregiver faces a major problem, in one hand the need to wean properly and quickly and on the other the risk of reintubation.

In order to help the clinician making the good choice, the spontaneous breathing trial (SBT) is a key tool. The international literature provides the investigators many ways to perform the SBT. The most common is the T-piece; the patient is disconnected from the ventilator and connected to a T-piece that can provide supplemental oxygen. Another one is the Support pressure trial, the patient is still connected to the ventilator, but the setups are changed to recreate the T-piece conditions.

In many French ICU's, the SBT is performed by using a heat humidifier filter that is directly connected to the endotracheal tube, this filter allows the clinician to provide supplemental oxygen in accordance with the patient need.

In high risk for reintubation patients, the SBT can create physical stress, that lead to prolonged MV.

In our ICU, for those patients, the investigators perform the SBT by connecting the patient to a device that provides high flow oxygen trough endotracheal connector for tracheotomy.

The investigators hypothesis that high flow oxygen SBT, will allow the high risk for reintubation patients to succeed the SBT.

Read the detailed description

The investigators proposed to compare 2 strategies for SBT in high risk for reintubation patients:

  1. Classic SBT (C-SBT)
  2. High Flow Oxygen SBT (HFO-SBT)

This prospective randomized study had 2 conjoint primary outcome:

  1. The HFO-SBT shows a better actuarial rate for extubation at day 7 from the begin of the weaning phase
  2. Compare the reintubation rate at D7 from the extubation
02

Conditions studied

  • Mechanical Ventilation
  • Mechanical Ventilator Weaning
  • Endotracheal Extubation

Keywords

  • Spontaneous breathing Trial
  • High Flow Oxygen
03

In context

Respiratory Aspiration

1,092 studies on the registry are indexed under Respiratory Aspiration; 216 are open to participants now.

This study's enrollment of 106 is above the median of 42 across 881 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Centre Hospitalier Régional d'Orléans is the lead sponsor of 129 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age > 18 yrs.
  • Admission in ICU
  • Mechanically ventilated > 24 hours
  • Mechanically ventilated using support ventilation mode
  • Patient with one of these criterion:

    • Cardiac disease (left ventricular dysfunction LVEF \<46%, antecedent of ischemic heart disease, antecedent of acute pulmonary edema)
    • Respiratory disease (COPD, Emphysema, bronchectiasis, asthma, obesity-hypoventilation syndrome, restrictive pulmonary disease)
  • Informed and signed consent from the patient or next of kin.

Exclusion criteria

Exclusion Criteria:

  • Head trauma as a cause for ICU admission
  • Neuromuscular disease prior ICU admission
  • Tracheotomized patient
  • Pregnancy
  • Decision not to forgo life sustaining therapy
  • Patient not affiliated with a social security organism
  • Adult private from his liberty with judicial decision
  • Patient that have already been included in the study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
106 participants (actual)

Study arms

  • No intervention
    1. Classic SBT (C-SBT)

    The patient is disconnected from the ventilator and remains 30 minutes without support but oxygen delivered through a heat humidifier filter that is usually connected on tracheotomy.

  • Experimental
    2. High Flow Oxygen SBT (HFO-SBT)

    The patient is disconnected from the ventilator and remains 30 minutes without support but high flow oxygen delivered through a dedicated piece that is usually connected on tracheotomy.

    Procedure: High Flow Oxygen SBT

Interventions

  • ProcedureHigh Flow Oxygen SBT

    The patient is disconnected from the ventilator and remains 30 minutes without support but high flow oxygen delivered through a dedicated piece that is usually connected on tracheotomy.

06

What researchers measure

Primary outcomes

  1. Actuarial rate of extubation

    This prospective randomized study had 2 conjoint primary outcomes to ensure the safety for the patients: 1. The HFO-SBT shows a better actuarial rate for extubation at day 7 from the begin of the weaning phase 2. Compare the reintubation rate at D7 from the extubation This prospective randomized study had 2 conjoint primary outcomes to ensure the safety for the patients: 1. The HFO-SBT shows a better actuarial rate for extubation at day 7 from the begin of the weaning phase 2. Compare the reintubation rate at D7 from the extubation

    Time frame: Day 7

  2. Reintubation Rate

    This prospective randomized study had 2 conjoint primary outcomes to ensure the safety for the patients: 1. The HFO-SBT shows a better actuarial rate for extubation at day 7 from the begin of the weaning phase 2. Compare the reintubation rate at D7 from the extubation

    Time frame: Day 7

Secondary outcomes

  1. Success rate of the first SBT

    Success rate of the first SBT will be compared between the two groups.

    Time frame: Day 0

  2. Ventilator free-days

    Ventilator free-days at day 28 from the admission in ICU

    Time frame: Day 28

  3. Rate of Ventilator Associated Pneumonia

    Rate of Ventilator Associated Pneumonia at day 7 from the extubation

    Time frame: Day 7

07

Study locations

1 site
  • CHR d'Orleans
    Orléans, 45067, France
08

References and documents

Publications

  • Thille AW, Richard JC, Brochard L. The decision to extubate in the intensive care unit. Am J Respir Crit Care Med. 2013 Jun 15;187(12):1294-302. doi: 10.1164/rccm.201208-1523CI. PubMed 23641924 ↗
  • Ladeira MT, Vital FM, Andriolo RB, Andriolo BN, Atallah AN, Peccin MS. Pressure support versus T-tube for weaning from mechanical ventilation in adults. Cochrane Database Syst Rev. 2014 May 27;2014(5):CD006056. doi: 10.1002/14651858.CD006056.pub2. PubMed 24865303 ↗
  • Brochard L, Rauss A, Benito S, Conti G, Mancebo J, Rekik N, Gasparetto A, Lemaire F. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med. 1994 Oct;150(4):896-903. doi: 10.1164/ajrccm.150.4.7921460. PubMed 7921460 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03689309
Lead sponsor
Centre Hospitalier Régional d'Orléans
Responsible party
Sponsor
First posted
Sep 28, 2018
Start date
Oct 16, 2018
Primary completion
Jul 15, 2020
Completion
Jul 15, 2020
Last update
Jul 27, 2020

Study contacts

Mai-Anh NAY, Dr
principal investigator · CHR d'Orléans

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion